The FDA calls for urgent action on the Dame Laura Cox report
On the day the House of Commons Commission meets to consider the Dame Laura Cox inquiry into bullying and harassment, the FDA has implored the Commission to “vote to implement Dame Laura’s recommendations in full and immediately”.
FDA Assistant General Secretary Amy Leversidge told Sky News’ Adam Boulton: “More than 200 members of staff went Dame Laura and worryingly, her report said more would have come forward but they didn’t trust that there wouldn’t be an impact on their careers.”
“We think that anything less than implementing Dame Laura’s recommendations in full will be seen by staff as a whitewash.”
The union also issued a press release, which was reported by the Mail and the Guardian.
The FDA welcomed the Dame Laura Cox report when it was published on 15 October, and wholeheartedly supports her recommendations in its statement.
Following the report publication, FDA Assistant General Secretary Amy Leversidge, wrote an article in the Timesspoke to Nick Ferrari on LBC; wrote an opinion piece for the Guardian and an article for the Huffington Posthere). She also spoke to the Today programme on Radio 4 (at 7:30) which you can listen to here, and wrote an article for The House magazine.
FDA General Secretary Dave Penman also wrote to all the Party leaders and all the members of the House Commission (the employer in the House of Commons) asking them if they support Dame Laura’s recommendations and to commit to implement them without delay.
You can keep track of the latest news on the FDA’s work in the House of Commons by following us on Twitter @FDA_Union@FDAGenSec@Amy_Leversidge.
If you are not a member of the FDA or know of colleagues who are not members you can join us today.
Related News
-
“Significant victory” for FDA members: MPs vote to introduce risk-based exclusion at the point of arrest
FDA welcomes MPs vote to introduce a formal mechanism to risk assess any MP at the point of arrest.
-
FDA calls on Senedd to implement “fully independent process for dealing with complaints of bullying, harassment and sexual harassment”
FDA Cymru|Wales has called on the Senedd to “implement a fully independent process for dealing with complaints of bullying, harassment and sexual harassment” made against MSs.
-
Announcement on risk-based exclusion in Parliament a “significant victory”, says FDA
Updated proposals on a risk-based exclusion policy in Parliament from the House of Commons Commission are a “significant victory” for the FDA and should now be implemented without delay.